PATENT CLAIM ANALYSIS

Application Number: 16005969
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "552000"]

Abstract:
In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dL to about 500 mg/dL, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof

Claim (Index 21):
A method of reducing risk of a cardiovascular event in a subject on statin therapy (a) with residual atherogenic dyslipidemia and clinically evident cardiovascular disease or (b) without clinically evident cardiovascular disease but with increased risk of cardiovascular disease, the method comprising administering to the subject a pharmaceutical composition comprising about 4 g of ethyl icosapentate per day for a period of at least about 2 years, wherein said administration reduces risk of cardiovascular death, need for coronary revascularization, risk of unstable angina, risk of stroke and/or risk of myocardial infarction.

Metadata:
- Claim Count in Document: 104.0
- Percentile: 94.0
- Lexical Diversity: 1.78723
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16006003', '15427238', '16005852', '15422634', '15409244']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6930555683951295
- 35 USC 102 Novelty (BERT): 0.5715520498698639
- Combined Prediction Score: 0.6809052165426029
- Mean Citation Score: 387.461348
- Max Citation Score: 402.3078
- Similarity Product: 398.1687134341478

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test